Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Supha Pharmachem Ltd
Your Vote -
Buy
27.27%
Hold
38.64%
Sell
34.09%
27.27%
44 users have voted
Option Chain
Analyzes market sentiment, predicts Supha Pharmachem Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Supha Pharmachem - Corporate Insolvency Resolution Process (CIRP)-List of Creditors
-
Supha Pharmachem - Postponement Of Board Meeting Under Regulation 30 Of SEBI (LODR) Regulations, 2015
-
Supha Pharmachem - Intimation Of Receipt Of Order From National Company Law Tribunal (NCLT)
-
Supha Pharmachem - Submission Of Form A - PUBLIC ANNOUNCEMENT
-
Supha Pharmachem - Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)
-
Supha Pharmachem - Intimation Of Change In Registered Office
-
Supha Pharmachem - Board Meeting Intimation for Rescheduled Of Board Meeting On 09.03.2026
-
Supha Pharmachem - Board Meeting Intimation for Rescheduled Of Board Meeting On 25.02.2026
-
Supha Pharmachem - Intimation Of Postponement And Rescheduling Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulation
-
Supha Pharmachem - Announcement under Regulation 30 (LODR)-Demise
-
Supha Pharmachem - Board Meeting Intimation for Consider Un-Audited Financial Results/Statements (Standalone & Consolidated)
-
Supha Pharmachem - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Remedium Lifecare bags contract from UK-based Aster Biotech
-
Remedium Lifecare bags order in UAE
Key fundamentals
Evaluate the intrinsic value of Supha Pharmachem Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1184.6883 | 100.6603 | 10.3643 | 4.9382 | 14.3591 |
| Liabilities | 1184.6883 | 100.6603 | 10.3643 | 4.9382 | 14.3591 |
| Equity | 40.32 | 10.08 | 3.6 | 3.6 | 3.6 |
| Gross Profit | -1.8107 | 33.3029 | 7.4713 | 1.7059 | 0.7109 |
| Net Profit | 1.532 | 32.7302 | 5.4261 | 1.0778 | 0.4805 |
| Cash From Operating Activities | 0 | -74.1611 | 20.5 | 11.283 | -10.2125 |
| NPM(%) | 0.68 | 0.8 | 1.06 | 0.21 | 0.53 |
| Revenue | 222.4976 | 4041.7067 | 509.8366 | 504.7919 | 90.0339 |
| Expenses | 224.3083 | 4008.4038 | 502.3653 | 503.086 | 89.323 |
| ROE(%) | 1.45 | 31.11 | 5.15 | 1.02 | 0.45 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Supha Pharmachem Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Neetu Yoshi Ltd | 96.70 | 5.07 | 0.00 | 1.08 | 84.58 | 0.00 |
| Resourceful Automobile Ltd | 35.51 | -15.43 | 4.35 | 0.10 | 47.70 | 0.00 |
| Kross Ltd | 186.00 | 0.84 | 24.08 | 2.45 | 148.90 | 0.00 |
| Belrise Industries Ltd | 206.20 | 1.98 | 38.45 | 24.74 | 79.89 | 0.00 |
Company Info
Remedium which engages in trading in API intermediates (KSMs & CRMs) and various other raw materials used in API trading. viz., Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide(TMSI), has further strengthened its performance and presence in the pharma & healthcare domain. Remedium has made a paradigm shift by entering into the trading of intermediates and APIs and be reckoned as a leading contract trader and as a brand owner of advanced intermediates & APIs Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. 2020-Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd..2023-The Company has issued Bonus Shares in the Ratio of 9:5.-Company has splits its face value from Rs. 10/- to Rs. 5/-.2024-The Company has issued Bonus Shares in the Ratio of 3:1.2025-The company issued rights shares of Rs. 1 in the ratio of 61:50 at par.- Remlife Global Partners with JiyaYu to Replace Animal-Origin Inputs in APIs.2026-Company name has changed to Supha Pharmachem Ltd. from Remedium Lifecare Ltd.
Remedium which engages in trading in API intermediates (KSMs & CRMs) and various other raw materials used in API trading. viz., Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide(TMSI), has further strengthened its performance and presence in the pharma & healthcare domain. Remedium has made a paradigm shift by entering into the trading of intermediates and APIs and be reckoned as a leading contract trader and as a brand owner of advanced intermediates & APIs Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. 2020-Company name has changed to Remedium Lifecare Ltd. from Roxy Exports Ltd..2023-The Company has issued Bonus Shares in the Ratio of 9:5.-Company has splits its face value from Rs. 10/- to Rs. 5/-.2024-The Company has issued Bonus Shares in the Ratio of 3:1.2025-The company issued rights shares of Rs. 1 in the ratio of 61:50 at par.- Remlife Global Partners with JiyaYu to Replace Animal-Origin Inputs in APIs.2026-Company name has changed to Supha Pharmachem Ltd. from Remedium Lifecare Ltd.
Read More
Parent Organisation
Supha Pharmachem Ltd.
Founded
19/02/1988
Managing Director
NSE Symbol
FAQ
The current price of Supha Pharmachem Ltd is
The 52-week high for Supha Pharmachem Ltd is
The market capitalization of Supha Pharmachem Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Supha Pharmachem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Supha Pharmachem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Supha Pharmachem Ltd shares.
The CEO of Supha Pharmachem Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
